New Academy of Finland Centre of Excellence led by Johanna Ivaska selected for 2022-2029
Turku Bioscience is proud to announce that Johanna Ivaska has received Academy of Finland funding for her Center of Excellence ”Biological Barrier Mechanics and Disease: From molecular-scale to tissue-level understanding of signal integration and forces (BarrierForce)‘’ for period of 2022-2029. BarrierForce ( Barrierforce.utu.fi ) brings together five groups led by Prof. Johanna Ivaska (UTU), Pekka Lappalainen (HU), Pipsa Saharinen (HU), Ilpo Vattulainen (HU) and Sara Wickström (HU) with expertise in cell cytoskeleton and adhesions, tissue mechanics, vascular/epithelial barriers and scientific computing.
BarrierForce aims to decipher how the integrity and function of biological barriers in a body are controlled by the tissue environment, and by cell- and tissue-scale mechanics. BarrierForce will uncover the key principles of barrier mechanics and biology on the molecular-to-tissue level by using emerging and self-developed cutting-edge approaches combined with multi-scale biomolecular simulation models and artificial intelligence.
Professor Johanna Ivaska has also recently received 1,000,000 Eur funding from Jane and Aatos Erkko foundation for her research project “Cancer metastasis – new biological paradigms as drug targets.”
Warmest congratulations, Johanna!
Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026